SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: ColleenB who wrote (2787)7/8/1998 9:29:00 AM
From: Profiteer  Respond to of 5402
 
ColleenB:.Dr. Drees pointed out, as impressive as the cancer application would be, speaking as a business man, this country has a million and a half heart attacks a year, a million cancer patients, six or seven hundred thousand stroke patients, BUT 12 MILLION transfusions. So transfusions is where the market is at this time.



To: ColleenB who wrote (2787)7/8/1998 9:30:00 AM
From: Prospector  Read Replies (1) | Respond to of 5402
 
Dr Drees also said there were about 150 applications for PHER-02 that he could name off the top of his head. Each one was very valuable..

So this PHER-02 is very very valueable...

big BIG gold nugget

Prospector


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News